Deficiency of alpha1-antitrypsin and bronchiectasis. 1978

E Varpela, and J Koistinen, and O Korhola, and H Keskinen

60 consecutive patients with bronchiectasis were screened for alpha1-antitrypsin deficiency. Six cases (10%) with genotype PiMZ (alpha1-antitrypsin less than 66% of normal) were found. This frequency (10%) was statistically significantly (p less than 0.005) higher than the frequency of PiMZ (2.7%) in the control group. In two patients the bronchiectasis was cystic. It is suggested that the deficiency states of alpha1-antitrypsin promoting the proteolysis can participate in the genesis of bronchiectasis.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001987 Bronchiectasis Persistent abnormal dilatation of the bronchi. Cylindrical Bronchiectasis,Cystic Bronchiectasis,Saccular Bronchiectasis,Varicose Bronchiectasis,Bronchiectases,Bronchiectasis, Cylindrical,Bronchiectasis, Cystic,Bronchiectasis, Saccular,Bronchiectasis, Varicose,Cylindrical Bronchiectases,Cystic Bronchiectases,Saccular Bronchiectases,Varicose Bronchiectases
D005260 Female Females
D005838 Genotype The genetic constitution of the individual, comprising the ALLELES present at each GENETIC LOCUS. Genogroup,Genogroups,Genotypes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D019896 alpha 1-Antitrypsin Deficiency Deficiency of the protease inhibitor ALPHA 1-ANTITRYPSIN that manifests primarily as PULMONARY EMPHYSEMA and LIVER CIRRHOSIS. Deficiencies, alpha 1-Antitrypsin,Deficiency, alpha 1-Antitrypsin,alpha 1 Antitrypsin Deficiency,alpha 1-Antitrypsin Deficiencies

Related Publications

E Varpela, and J Koistinen, and O Korhola, and H Keskinen
February 1975, Chest,
E Varpela, and J Koistinen, and O Korhola, and H Keskinen
December 2007, American journal of respiratory and critical care medicine,
E Varpela, and J Koistinen, and O Korhola, and H Keskinen
July 2008, American journal of respiratory and critical care medicine,
E Varpela, and J Koistinen, and O Korhola, and H Keskinen
April 1977, Chest,
E Varpela, and J Koistinen, and O Korhola, and H Keskinen
February 2004, Thorax,
E Varpela, and J Koistinen, and O Korhola, and H Keskinen
February 2004, Thorax,
E Varpela, and J Koistinen, and O Korhola, and H Keskinen
November 2009, The New England journal of medicine,
E Varpela, and J Koistinen, and O Korhola, and H Keskinen
January 1976, Birth defects original article series,
E Varpela, and J Koistinen, and O Korhola, and H Keskinen
April 2020, The New England journal of medicine,
E Varpela, and J Koistinen, and O Korhola, and H Keskinen
January 2005, Lancet (London, England),
Copied contents to your clipboard!